Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UConn Chemist Discovers New Way to Stabilize Proteins

Published: Wednesday, December 11, 2013
Last Updated: Wednesday, December 11, 2013
Bookmark and Share
Discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.

The team’s novel approach involves wrapping the polymer poly(acrylic acid) around hemoglobin, protecting it from the intense heat used in sterilization and allowing it to maintain its biological function and structural integrity.

In addition to having potential applications in the stabilization of vaccines and development of inexpensive artificial blood, the stabilizing polymer also allows vaccines and other biomedical products to be stored for longer periods without refrigeration. It could also have applications in biomaterials, biosensors, and biofuels.

“Protein stability is a major issue in biotechnology,” says Challa V. Kumar, UConn professor of chemistry and biochemistry and the primary investigator on the project. “What we’ve done is taken this protein molecule and wrapped it up in a polymer chain in order to stabilize it. In thermodynamics terms, we have restricted the entropy of the denatured state of the protein and stabilized it beyond our expectations. The system also exhibits a high degree of reversibility. The protein can be denatured and renatured many, many times. This is the very first example of its kind in the literature of all protein science. No one has ever been able to achieve this kind of stability for proteins.”

A popular example of denaturation can be found in the protein present in eggs. As the egg is cooked and the protein around the yolk turns white, the protein in the egg is denatured and cannot return to its prior, natural state. Likewise, when proteins in a living cell are exposed to heat they become denatured, which disrupts their activity and can lead to cell death. When protein is a critical element in a vaccine and breaks down, the product becomes useless.

In searching for a viable material to serve as a protein stabilizer, Kumar’s team found one that is readily available, inexpensive, and can be modified chemically for further improvements.

The poly(acrylic acid) used in the study is the same material found in disposable diapers, and one of the most abundant synthetic polymers on the planet. This particular polymer, says Kumar, is very hydrophilic, meaning it likes water. The polymer naturally binds to hemoglobin, creating a tight seal that protects the protein molecule and allows it to retain its structural integrity even after heating it to 120˚C for extended periods of time (steam sterilization).

Joining him on the project was Rajeswari Kasi, associate professor of chemistry, an expert in synthetic polymers and hybrid materials. The research team also included graduate students: Vamsi Mudhivarthi, Kyle Cole, Inoka Deshapriya, Caterina Riccardi, and Yuxiang Zhou, as well as undergraduate students Marc Novak and Westley Kipphut.

Kumar is proud of the fact that undergraduates participated in such a major research endeavor. “One of our missions at the University is to train undergraduates in research,” he says, “and we take that very seriously.”

The team tested various protein-polymer compositions using transmission electron microscopy (TEM) and optical spectroscopy techniques. The research was supported by multiple grants from the National Science Foundation, topping $3 million over the past 10 years.

In a paper published last year in the Journal of Materials Chemistry, Kumar and his team showed how hemoglobin wrapped in low molecular weight poly(acrylic acid) formed nanoparticles that retained their natural state and structure, even after they were subjected to the harsh conditions of steam sterilization. Under the same conditions, hemoglobin samples that were not wrapped in the polymer lost the majority of their structure and function.

Kumar said these test results signaled the project’s breakthrough moment.

As part of its research, the team chose to examine the feasibility of using hemoglobin as an artificial blood substitute. Hemoglobin, when extracted from blood, breaks down and is toxic in its pure form. Since hemoglobin is the critical oxygen carrier protein in blood, Kumar and his team are looking at ways of stabilizing hemoglobin in its natural form so that it retains its activity and stays harmless when administered as a transfusion agent. This could lead to a new substitute for human blood, which is frequently in short supply. Blood shortages are expected to get worse in coming years, as more and more people in the world are likely to need blood transfusions, Kumar said.

The research has caught the attention of scientists at Merck, a global leader in prescription medicine, vaccines, and biologic therapies.

“Being able to control the placement of proteins in polymer matrices of defined size brings exciting opportunities for producing potent and heat-stable vaccine antigens,” says Henryk Mach, a senior investigator with Merck’s vaccine drug product development division. “Prof. Kumar’s work may well provide technologies for vaccine delivery in the developing world.”

The abundance of the polymer, the flexibility of the process, and the simplicity of the approach enhances its potential for mass production, Kumar says. Kumar and the rest of the UConn research team are working with the University’s Technology Partnerships and Licensing group of UConn’s Office of Economic Development and a U.S. patent application has been filed for the new technology.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Personalized Ovarian Cancer Vaccines
UConn Researchers have found a new way to identify protein mutations in cancer cells.
Thursday, October 09, 2014
Embryonic Stem Cells Offer Treatment Promise for Multiple Sclerosis
Embryonic stem cell therapy offers better treatment results than human adult bone marrow derived stem cells.
Friday, June 13, 2014
Stem Cells that “Fool” Immune System May Provide Vaccination for Cancer
Health Center researchers have revealed the potential for human stem cells to provide a vaccination against colon cancer.
Friday, November 27, 2009
Stem Cells Which "Fool Immune System" May Provide Vaccination for Cancer
Scientists from China have revealed the potential for human stem cells to provide a vaccination against colon cancer.
Tuesday, October 13, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!